期刊文献+

叶酸和辛伐他汀对高同型半胱氨酸血症引起的大鼠动脉粥样硬化疗效对比 被引量:2

Comparison between folic acid and simvastatin treatment effects on the rats with atherosclerosis induced by hyperhomocysteinemia
下载PDF
导出
摘要 目的探讨叶酸及辛伐他汀对高同型半胱氨酸血症(HHcy)引起的大鼠动脉粥样硬化(AS)治疗效果的差异。方法将36只健康8周龄SD雄性大鼠随机分为健康对照组、高蛋氨酸饮食组、叶酸治疗组和辛伐他汀治疗组。12周后,采用高效液相色谱法检测血浆同型半胱氨酸(Hcy)浓度;采用酶法检测血脂浓度;通过光镜和电镜观察胸主动脉形态学变化;采用免疫组织化学方法检测胸主动脉平滑肌细胞中依赖正常T细胞激活表达和分泌的因子(RANTES)、趋化因子受体-1(CCR-1)蛋白的表达;采用反转录-聚合酶链反应(RT-PCR)方法检测胸主动脉平滑肌细胞RANTES、CCR1 mRNA的表达。结果高蛋氨酸饮食组血浆Hcy浓度明显高于其余3组;叶酸治疗组血浆Hcy浓度明显低于辛伐他汀治疗组(P<0.05)。各组大鼠血浆总胆固醇与甘油三酯浓度差异无统计学意义(P>0.05)。光镜和电镜下可见健康对照组大鼠胸主动脉壁基本结构正常,高蛋氨酸饮食组大鼠胸主动脉呈AS早期改变,治疗组大鼠动脉病变较轻。免疫组织化学结果显示,RANTES和CCR-1蛋白在高蛋氨酸饮食组主动脉平滑肌细胞中表达的平均灰度值显著低于其余3组。且在叶酸治疗组表达的平均灰度显著低于辛伐他汀治疗组(P<0.05)。RT-PCR结果亦表明RANTES和CCR-1 mRNA均在高蛋氨酸饮食组主动脉平滑肌细胞中的表达最高。且在叶酸治疗组的表达均显著高于辛伐他汀治疗组(P<0.05)。结论高蛋氨酸饮食能引起大鼠HHcy形成,促进主动脉平滑肌细胞中RANTES及受体CCR-1的表达,进而诱导AS发生,此过程与血脂无关。辛伐他汀及叶酸均可降低血浆Hcy浓度、抑制动脉壁平滑肌细胞中RANTES及CCR-1的表达,减轻Hcy对动脉壁的损伤,防止AS的发生,但以叶酸降低血浆Hcy的作用更强,辛伐他汀对RANTES和CCR-1表达的抑制作用更明显。 Objective To investigate the comparison between the folic acid and simvastatin treatment effects on the rats with atherosclerosis (AS) induced by hyperhomocysteinemia (HHcy). Methods Thirty-six healthy 8- week-old SD male rats were randomly divided into normal control group, high methionine diet group, folic acid treatment group and simvastatin treatment group. Twelve weeks later, the plasma homocysteine(Hcy) concentrations were detected by high performance liquid chromatography (HPLC). The concentrations of plasma lipid were determined with enzyme method. The morphological alterations were detected by optics microscope and transmission electron microscope. The expressions of regulated upon activation normal T expression and secretion (RANTES) and chemoattractant cytokines receptor-1 (CCR-1) proteins in aortic smooth muscle cells were assayed with immunohistochemistry. The expressions of RANTES and CCR-1 mRNA were detected with reverse transcription- polymerase chain reaction (RT-PCR). Results Hcy concentrations in the plasma of rats fed by high methionine diet were significantly higher than those in the other three groups, and the plasma Hcy concentrations of rats treated with folic acid were dramatically lower than those in the group treated with simvastatin (P〈0.05). There were no significant differences about plasma total cholesterol and triglyceride concentrations of rats between different groups (P〉0. 05). The optic microscope and transmission electron microscope showed that the basic structure of thoracic aortic of normal control group was not altered, the thoracic aortas of high methionine diet group were with AS early alterations, and the alterations in the treatment group were lightened. The immunohistochemistry showed the average grey values of RANTES and CCR-1 proteins in the high methionine diet group were significantly lower than those in the other three groups. The average grey values of RANTES and CCR-1 proteins of the folio acid treatment were dramatically lower than those in the simvastatin treatment group (P〈0.05). RT-PCR showed the expressions of RANTES and CCR-1 mRNA in the high methionine diet group were significantly higher than those in the other three groups. And the expressions of RANTES and CCR-1 mRNA of the folio acid treatment were dramatically higher than those in the simvastatin treatment group (P〈0.05). Conclusion The high methionine diet can lead to HHcy in rats, increase the expressions of RANTES and CCR-1 in smooth muscle cells of the aorta, and exacerbate atherogenesis, but high methionine diet can not result in higher lipidemia. Both of simvastatin and folic acid can decrease the concentrations of plasma Hey, inhibit RANTES and CCR-1 expressions in arterial smooth muscle cells of rats with HHcy, reduce the injury of aorta walls induced by Hcy, and prevent atherogenesis. The folio acid may play a more important role in reducing the concentration of plasma Hey, and simvastatin much more significantly inhibits the expressions of RANTES and CCR-1.
出处 《山西医药杂志(上半月)》 CAS 2009年第8期705-708,共4页 Shanxi Medical Journal
关键词 半胱氨酸 大鼠 蛋氨酸 辛伐他汀 叶酸 动脉粥样硬化 Cysteine Rat, Methionine Simvastatin Folic acid Atherosclerosis
  • 相关文献

参考文献7

  • 1Durand P,Prost M,Loreau N,et al.Impaired homocysteine metabolism and atherothromobotic disease.Lab Invest,2001,81(5):645-672.
  • 2Mattson MP,Shea TB.Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.Trends Neurosci,2003,26(3):137-146.
  • 3Ball RO,Courtney-Martin G,Pencharz PB.The in vivo sparing of methionine by cysteine in sulfur amino acid requirements in animal models and adult humans.J Nutr,2006,136(6 Suppl):1682S-1693S.
  • 4Stead LM,Au KP,Jacobs RL,et al.Methylation demand and homecysteine metabolism:effects of dietary provision of creation and guanidinoacetate.Am J Physiol Endocrinol Metab,2001,281(5):1095-1100.
  • 5陈小莉,杨庆,蔡东联,胡同杰,李燕,卫立辛.同型半胱氨酸促进血管平滑肌细胞增生的实验研究[J].营养学报,2002,24(4):385-388. 被引量:11
  • 6Hamed SA,Nabeshima T.The high atherosclerotic risk among epileptics:the atheroprotective role of multivitamins.J Pharmacol Sci,2005,98(4):340-53.
  • 7许从峰 熊思东 杨英珍.RANTES 生物功能的多样性[J].生命的化学,2001,21(5):353-354.

二级参考文献4

  • 1Armando D,Selhub J. Homocysteine and thrombotic disease [J]. Blood,1997,90:1-11.
  • 2Michiaki U,Hidehiro M,Hiroshi M,et al. Endothelial dysfunction by acute hyperhomocysteinaemia :restoration by folic acid [J]. Clinical Science,1999,96,235-239.
  • 3Tsai JC,Perrella MA,Yoshizumi M,et al. Promotion of vascular smooth muscles cell growth by homocysteine: A link to atherosclerosis [J]. Proc Natl Acad Sci USA,1994,91:6369-6373.
  • 4蔡东联,陈小莉.高效液相测定同型半胱氨酸方法的建立[J].氨基酸和生物资源,2001,23(1):48-51. 被引量:12

共引文献11

同被引文献25

  • 1唐元升,朱兴雷,罗静,刘莹,耿庆信,马晓静,陈良华.通心络对实验家兔血管球囊损伤后血管重构的抑制作用[J].中华心血管病杂志,2004,32(12):1147-1147. 被引量:15
  • 2葛华,王璇,赵雅琳,罗丽丽.通心络对高血压大鼠血管内皮功能的保护作用[J].中国心血管杂志,2006,11(2):89-91. 被引量:21
  • 3房振英,白玉.辛伐他汀对急性冠状动脉综合征炎症因子和内皮功能的影响[J].中国药物与临床,2007,7(3):178-181. 被引量:2
  • 4Luster AD. Chemokines: chemotatic cytokines that mediate inflammation. N Engl J Med, !998,338 : 436-445.
  • 5Sakai M, Kobori S,Matsumura T,et al. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis, 1997,133 : 51-59.
  • 6Taubman MB,Fallon JT,Schecter AD,et al. Tissue factor in the pathogenesis of atherosclerosis. Thromb Haemost, ! 997,78 : 200- 204.
  • 7Edgington TS,Mackman N,Brand K,et al. The structural biology of expression and function of tissue factor. Thromb Haemost, 1991,66 : 67-79.
  • 8Wilcox JN,Smith KM,Schwartz SM,et al. Localization of tissue factor in the normal vessel wall and in the athersclerotic plaque. Proc Natl Acad Sci USA, 1989,86: 2839-2843.
  • 9Tiruvikraman SV,Guha A,Roboz J,et al. In situ localization of tissue factor in human atberosclerotic plaques by binding of digoxigenin-labeled factors Ⅶa and X. Lab Invest,1996,75: 451-461.
  • 10Marmur JD,Tiruvikraman SV, Fyfe BS,et al. Identification of active tissue factor in human coronary atheroma. Circulation, 1996, 94: 1226-1232.

引证文献2

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部